The United States Food and Drug Administration (FDA) has announced a series of nationwide recalls of dietary supplements.
It was said that the recall came after tests and routine inspections uncovered undeclared prescription medicines, potentially dangerous chemicals and allergens that could pose “life-threatening” health risks.
Among the products affected are all batches of Silintan capsules, marketed for joint and body aches.
The supplement was voluntarily recalled by Anthony Trinh, trading as 123Herbals, after the FDA found it contained meloxicam, a prescription-only non-steroidal anti-inflammatory drug.
The agency warned that exposure to meloxicam beyond approved doses can increase the risk of serious side effects, including heart attack, stroke, internal bleeding and kidney damage.
Silintan was sold nationwide through 123herbals.com in blue-labelled plastic bottles containing 25 capsules.
No adverse reactions had been reported at the time of publication, however, the FDA said the distributor is contacting customers and distributors by email to arrange returns and has advised consumers to stop using the product immediately.
In a separate action, HerbsForever has recalled specific batches of Hingwastik Churna powder, Gastro Care supplements and Hingwastika extract capsules after they were found to potentially contain undeclared wheat.
The allergen, discovered during a routine FDA inspection at a manufacturing facility in India, poses a serious risk to people with wheat allergies.
It said the affected Hingwastik Churna Powder was sold in 100-gram amber bottles with UPC 807814006224, batch number 622-2 and an expiry date of June 2029.
The Hingwastika extract capsules carry UPC 807814001335, batch number 133-14, with an expiry date of April 2029.
Gastro Care was packaged in white plastic bottles containing 90 capsules, marked with UPC 807814001243, batch number 124-4, and an expiry date of January 2029.
The products were distributed nationwide by mail order, with no illnesses reported so far, reports insisted.
Another recall involves all lots of “Modern Warrior Ready” capsules, produced by Modern Warrior and promoted as a metabolism booster and appetite suppressant.
Regulatory testing found the product contained undeclared tianeptine, 1,4-DMAA and aniracetam.
The FDA said tianeptine is not approved for use in dietary supplements in the United States and can cause severe neurological and psychiatric effects, while 1,4-DMAA is linked to elevated blood pressure and cardiovascular complications, including heart attacks and breathing difficulties.
The supplement was sold online nationwide between April 2022 and 8 December 2025 in black plastic bottles containing 60 capsules.
Modern Warrior has halted distribution, quarantined remaining stock and urged consumers to stop using the product.
Consequently, the FDA advised consumers to check its recall database for the latest updates on food and dietary supplement recalls in the United States.
READ ALSO: Nestlé Recalls Infant Formula Batches in Over 50 Countries